Follow the people · Insider

PD

Pravin Dugel

Insider · Director and Officer · OCUL

Pravin Dugel files insider transactions with the SEC as a director and officer of Ocular Therapeutix (OCUL). We hold 4 disclosed purchases and sales filed since 22 June 2018, 1 of them in the last 90 days.

  • Files forOCUL
  • Disclosed buys and sells4 in all, 1 in the last 90 days
  • Last disclosure26 August 2026

Positions held

3 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 22 February 202425 August 2026Director and Officer · Ocular Therapeutix (OCUL)33 Form 4 lines · source: SEC Form 4
  • Filed 18 December 202011 July 2023President · IVERIC bio (ISEE)42 Form 4 lines · source: SEC Form 4
  • Filed 20 June 201830 June 2021Director · Aerpio Pharmaceuticals (ARPO)7 Form 4 lines · source: SEC Form 4

Everything they disclosed

82 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.